Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Diagnostic accuracy of an antigen-based point-of-care test versus nucleic acid amplification testing for genital trichomoniasis among pregnant women attending antenatal care facilities in Zambia

Fig. 2

STARD 2015 flow diagram. * Used metronidazole (MTZ) or clindamycin (CLM) during current pregnancy; † Used or performed any of the following within 72 h of visit: (i) vaginal cream or ointment product, (ii) douching, or (iii) spermicides, vaginal lubricants, or feminine sprays

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us